Merck & Co.'s COVID-19 therapy pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus, and it would soon ask health officials in the U.S. and around the world to authorize its use, the company said. Newsday's Cecilia Dowd reports. Credit: Kendal Rodriguez; Merck

4th of july sale

Digital Access

25¢

for
6 MONTHS

CELEBRATE NOW >Cancel anytime - New subscribers only